superselective catheterization
Recently Published Documents


TOTAL DOCUMENTS

22
(FIVE YEARS 1)

H-INDEX

8
(FIVE YEARS 0)

2020 ◽  
Vol 26 (5) ◽  
pp. 456-463
Author(s):  
Tunyarat Wattanasatesiri ◽  
◽  
Jin Wook Chung ◽  
Tae Won Choi ◽  
Hyo-Cheol Kim ◽  
...  

2016 ◽  
Vol 22 (4) ◽  
pp. 457-465 ◽  
Author(s):  
Athos Patsalides ◽  
Lewis Z Leng ◽  
David Kimball ◽  
Joshua Marcus ◽  
Jared Knopman ◽  
...  

Objective The existing literature regarding preoperative cervical spinal tumor embolization is sparse, with few discussions on the indications, risks, and best techniques. We present our experience with the preoperative endovascular management of hypervascular cervical spinal tumors. Methods We performed a retrospective review of all patients who underwent preoperative spinal angiography (regardless of whether tumor embolization was performed) at our institution (from 2002 to 2012) for primary and metastatic cervical spinal tumors. Tumor vascularity was graded from 0 (tumor blush equal to the normal adjacent vertebral body) to 3 (intense tumor blush with arteriovenous shunting). Tumors were considered “hypervascular” if they had a tumor vascular grade from 1 to 3. Embolic materials included particles, liquid embolics, and detachable coils. The main embolization technique was superselective catheterization of an arterial tumor feeder followed by injection of embolic material. This technique could be used alone or supplemented with occlusion of dangerous anastomoses of the vertebral artery as needed to prevent inadvertent embolization of the vertebrobasilar system. In cases when superselective catheterization of the tumoral feeder was not feasible, embolization was performed from a proximal catheter position after occlusion of branches supplying areas other than the tumor (“flow diversion”). Results A total of 47 patients with 49 cervical spinal tumors were included in this study. Of the 49 total tumors, 41 demonstrated increased vascularity (vascularity score > 0). The most common tumor pathology in our series was renal cell carcinoma (RCC) ( N = 16; 32.7% of all tumors) followed by thyroid carcinoma ( N = 7; 14.3% of all tumors). Tumor embolization was undertaken in 25 hypervascular tumors resulting in complete, near-complete, and partial embolization in 36.0% ( N = 9), 44.0% ( N = 11), and 20.0% ( N = 5) of embolized tumors, respectively. We embolized 42 tumor feeders in 25 tumors. The most commonly embolized tumor feeders were branches of the vertebral artery (19.0%; N = 8), the deep cervical artery (19.0%; N = 8), and the ascending cervical artery (19.0%; N = 8). Sixteen hypervascular tumors were not embolized because of minimal hypervascularity (8/16), unacceptably high risk of spinal cord or vertebrobasilar ischemia (4/16), failed superselective catheterization of tumor feeder (3/16), and cancellation of surgery (1/16). Vertebral artery occlusion was performed in 20% of embolizations. There were no new post-procedure neurological deficits or any serious adverse events. Estimated blood loss data from this cohort show a significant decrease in operative blood loss for embolized tumors of moderate and significant hypervascularity. Conclusions Preoperative embolization of cervical spinal tumors can be performed safely and effectively in centers with significant experience and a standardized approach.


2015 ◽  
Vol 39 (6) ◽  
pp. 920-926 ◽  
Author(s):  
Hiroyuki Morishita ◽  
Yoshito Takeuchi ◽  
Takaaki Ito ◽  
Natsuko Hayashi ◽  
Osamu Sato

Retina ◽  
2009 ◽  
Vol 29 (8) ◽  
pp. 1207-1209 ◽  
Author(s):  
CAROL L. SHIELDS ◽  
APARNA RAMASUBRAMANIAN ◽  
ROBERT ROSENWASSER ◽  
JERRY A. SHIELDS

2008 ◽  
Vol 109 (Supplement) ◽  
pp. 41-50 ◽  
Author(s):  
Ramiro Del Valle ◽  
Marco Zenteno ◽  
José Jaramillo ◽  
Angel Lee ◽  
Salvador De Anda

Object The cumulative experience worldwide indicates complete radiosurgical obliteration rates of brain arteriovenous malformations (AVMs) ranging from 35 to 90%. The purpose of this study was to propose a strategy to increase the obliteration rate for AVMs through the dynamic definition of the key target volume (KTV). Methods A prospective series of patients harboring an AVM was assessed using digital subtraction angiography in which a digital counter was used to measure the several stages of the frame-by-frame circulation time. All the patients were analyzed using dynamic measurement planning to define the KTV, corresponding to the volume of the shunt with the least vascular resistance and the earliest venous drainage. All patients underwent catheter-based angiography, a subgroup was additionally assessed by means of a superselective catheterization, and among these a further subgroup received embolization. The shunts were also categorized according to their angioarchitectural type: fistulous, plexiform, or mixed. The authors applied the radiosurgery-based grading system (RBGS) as well to find a correlation with the obliteration rate. Results This series includes 44 patients treated by radiosurgery; global angiography was performed for all patients, including dynamic measurement planning. Eighty-four percent of them underwent superselective catheterization, and 50% of the total population underwent embolization. In the embolized arm of the study, the pretreatment volume was up to 120 ml. In patients with a single treatment, the mean volume was 8.5 ml, and the median volume was 6.95 ± 4.56 ml (mean ± standard deviation), with a KTV of up to 15 ml. For prospectively staged radiosurgery, the mean KTV was 28 ml. The marginal radiation dose was 18–22 Gy, with a mean of dose 20 Gy. The mean RBGS score was 1.70. The overall obliteration rate was 91%, including the repeated radiosurgery group (4 patients), in which 100% showed complete obliteration. The overall permanent deficit was 2 of 44 patients, 1 in each group. Conclusions Dynamic definition of the KTV might increase the obliteration rate, even in complex AVMs, allowing the treatment of smaller volumes off the recruitment vessels (pseudonidus). By using this technique, the authors avoided double-blind treatment, where the neurosurgeon does not know precisely which type of lesion he or she is irradiating and the interventionalist does not know why and what he or she is embolizing.


2007 ◽  
Vol 8 (3) ◽  
pp. 225 ◽  
Author(s):  
Jee Hyun Baek ◽  
Jin Wook Chung ◽  
Hwan Jun Jae ◽  
Whal Lee ◽  
Jae Hyung Park

Sign in / Sign up

Export Citation Format

Share Document